Xeris Biopharma Says Q2 Rev Seen Exceeding $47M, Representing More Than 23% Growth Over Last Year >XERS
Xeris Biopharma Says Q2 Rev Seen Exceeding $47M, Representing More Than 23% Growth Over Last Year >XERS
Xeris Biopharma表示，預計第二季度收入將超過4700萬美元，比去年增長超過23％，＞ XERS
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊